aap

Strong sales increase (+23%) and EBITDA growth (>100%) in Q2; growth driver LOQTEQ® and Biomaterials

aap Implantate AG / aap: Strong sales increase (+23%) and EBITDA growth (>100%) in Q2; growth driver LOQTEQ® and Biomaterials . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

aap realized in the second quarter of 2014 sales of EUR 8.1 million (previous year: continued business operations EUR 6.6 million), a 23% increase compared to the previous year. EBITDA was EUR 1.5 million (previous year: continued business operations EUR 0.2 million) and EBIT was EUR 1.0 million (previous year: continued business operations EUR -0.3 million).  The group achieved sales growth to EUR 14.2 million in the first half of 2014 (previous year: EUR 12.6 million) with EBITDA at EUR 1.6 million (previous year: EUR 2.6 million).

Group (continued business operations)

In million EUR	Q2/2014	Q2/2013*	Change
Sales	8.1	6.6	23%
EBITDA	1.5	0.2	>100%
EBIT	1.0	-0.3	n.a.
*Figures refer solely to the continued business operations. Figures for previous year are adjusted

 

Group (continued business operations)

In million EUR	H1/2014	H1/2013*	Change
Sales	14.2	12.6	13%
EBITDA	1.6	2.6	-38%
EBIT	0.5	1.6	-69%
*Figures refer solely to the continued business operations. Figures for previous year are adjusted

 

On a like for like basis (without one-time effects from share disposal and project sales as well as costs involved) the figures of the continued business operations for the second quarter and the first six months of 2014 are as follows:

Operative Performance: continued business operations (normalized*)

In million EUR	Q2/2014	Q2/2013	Change
Sales	8.0	6.5	23%
EBITDA	0.3	-0.3	>100%
*Sales/EBITDA one-time effects from share disposal and project sales as well as costs involved

 

Operative Performance: continued business operations (normalized *)

In million EUR	H1/2014	H1/2013	Change
Sales	14.0	11.0	27%
EBITDA	0.4	-1.6	>100%
*Sales/EBITDA one-time effects from share disposal and project sales as well as costs involved

 

For the group (including EMCM B.V. for two months in 2014 and for six months in 2013), aap achieved sales of EUR 15.2 million in the first half of 2014 (previous year: EUR 19.6 million) with EBITDA at EUR 1.6 million (previous year: EUR 4.2 million).